Usfda Approval
Latest news, explainers and analysis on Usfda Approval. Tracking 2 stories on Arth Vani.
Connected in the graph
Latest on Usfda Approval
Alembic & NATCO Get USFDA Nod for Cancer Drug; Big Market Opportunity
Indian pharmaceutical firms Alembic Pharmaceuticals and NATCO Pharma have received tentative USFDA approval for a generic version of the cancer drug Olaparib. This approval opens up a significant market opportunity in the US, estimated at ₹11,660 crore, though the commercial launch is contingent on ongoing legal proceedings.
Concord Biotech Shares Jump 6% Following USFDA Approval for Arthritis Tablets
Shares of Concord Biotech rose sharply after the company received a green light from the US health regulator for its Tofacitinib tablets. This approval allows the firm to enter a lucrative $500 million US market for rheumatoid arthritis treatments.
Some listings may be sponsored and Arth Vani may earn a referral fee. All information is for educational purposes only — verify terms and suitability with the provider before acting. Not financial advice.